Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0019 | 0.5386 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0022 | 0.7623 | 0.7623 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0026 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.7623 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0012 | 0.0796 | 0.0796 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trypanosoma brucei | phosphatidylinositol kinase related protein, putative | 0.0026 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0019 | 0.5386 | 0.4987 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0019 | 0.5386 | 0.7065 |
Giardia lamblia | GTOR | 0.0019 | 0.5386 | 0.5 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0019 | 0.5386 | 0.4987 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0012 | 0.0796 | 0.0796 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Echinococcus granulosus | serine protein kinase ATM | 0.0026 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0796 | 0.1044 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Entamoeba histolytica | hypothetical protein | 0.0026 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0019 | 0.5386 | 0.5386 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0019 | 0.5386 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm) | 0.0026 | 1 | 1 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0019 | 0.5386 | 0.4987 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0026 | 1 | 1 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0019 | 0.5386 | 0.5386 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0019 | 0.5386 | 0.4987 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0019 | 0.5386 | 0.5386 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0019 | 0.5386 | 0.7065 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0019 | 0.5386 | 0.5386 |
Toxoplasma gondii | FATC domain-containing protein | 0.0026 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0019 | 0.5386 | 0.5386 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0019 | 0.5386 | 0.5386 |
Leishmania major | phosphatidylinositol kinase related protein, putative | 0.0019 | 0.541 | 1 |
Echinococcus multilocularis | serine protein kinase ATM | 0.0026 | 1 | 1 |
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trypanosoma cruzi | phosphatidylinositol kinase related protein, putative | 0.0019 | 0.541 | 0.541 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0019 | 0.5386 | 0.5386 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0019 | 0.5386 | 0.5386 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0019 | 0.5386 | 0.5386 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0019 | 0.5386 | 0.5386 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.